Center for Scientific Review; Notice of Closed Meetings, 55556 [2018-24224]
Download as PDF
<![CDATA[
55556
Federal Register / Vol. 83, No. 215 / Tuesday, November 6, 2018 / Notices
funded by HHS by conducting criminal,
civil, and administrative investigations
of fraud and misconduct related to HHS
programs, operations, and employees.
The office serves as OIG’s liaison to DOJ
on all matters relating to investigations
of HHS programs and personnel and
reports to the Attorney General when
there are reasonable grounds to believe
Federal criminal law has been violated.
OI serves as a liaison to CMS, State
licensing boards, and other outside
organizations and entities with regard to
exclusion, compliance, and enforcement
activities.
khammond on DSK30JT082PROD with NOTICES
Section QJ.10, Office of Investigations—
Organization
OI is directed by the Deputy Inspector
General for Investigations, aided by
Assistant Inspectors General, and
performs the functions designated in the
law (section 3(d)(1)(B) of the Inspector
General Act) for the position of
Assistant Inspector General for
Investigations. The office is comprised
of headquarters and regional functions.
Section QJ.20, Office of Investigations—
Functions
OI conducts criminal, civil, and
administrative investigations of
allegations of fraud, waste, abuse,
mismanagement, and violations of
standards of conduct within the
jurisdiction of OIG. OI establishes
investigative priorities, evaluates the
progress of investigations, and reports
findings to the Inspector General. The
office develops and implements
investigative techniques, programs,
guidelines, and policies; manages OI’s
quality assurance/peer-review program,
and conducts peer reviews of other
OIGs. OI also carries out and maintains
an internal quality assurance system.
The system includes quality assessment
studies and quality control reviews of
OI processes and products to ensure that
policies and procedures are followed
effectively and are functioning as
intended. The office effectuates
mandatory and permissive exclusions
from participation in Federal health care
programs under the Social Security Act;
decides on all requests for reinstatement
from, or waiver of, exclusions; and
participates in developing standards
governing the imposition of these
exclusion authorities. The office also
oversees OIG’s suspension and
debarment referral program. OI
implements policies and procedures
and plans, develops, implements, and
evaluates all levels of training for OI
employees. The staff provides for the
personal protection of the Secretary and
other Department officials, as needed,
and all emergency operations
VerDate Sep<11>2014
17:05 Nov 05, 2018
Jkt 247001
preparedness and response. OI
coordinates the adoption of advanced
digital forensic acquisition and
examination and information security
technologies to assist in the
investigation, prevention, and detection
of fraud and abuse; maintains an
automated data and management
information system used by all OI
employees; provides technical expertise
on computer applications for
investigations; and coordinates and
approves investigative computer
matches with other agencies. In
addition, the office operates a toll-free
hotline to permit individuals to report
suspected fraud, waste, and abuse
within HHS programs.
Daniel R. Levinson,
Inspector General.
[FR Doc. 2018–23935 Filed 11–5–18; 8:45 am]
BILLING CODE 4152–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR 17–
158: Secondary Data Analyses For NIMH
Research Domain Criteria (R03).
Date: November 28, 2018.
Time: 12:00 p.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Julius Cinque, MS,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5186,
MSC 7846, Bethesda, MD 20892, (301) 435–
1252, cinquej@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
conflict: AIDS and Related Research.
Date: November 29, 2018.
PO 00000
Frm 00043
Fmt 4703
Sfmt 4703
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Shalanda A Bynum, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3206,
Bethesda, MD 20892, 301–755–4355,
bynumsa@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Bone and Cartilage.
Date: November 29, 2018.
Time: 12:00 p.m. to 5:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Richard Ingraham, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4116,
MSC 7814, Bethesda, MD 20892, 301–496–
8551, ingrahamrh@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Role of
Blood Brain Barrier in Pain and Brain
Tumors, Peripheral Nerve and Brain Injury.
Date: November 30, 2018.
Time: 11:00 a.m. to 12:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Seetha Bhagavan, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5194,
MSC 7846, Bethesda, MD 20892, (301) 237–
9838, bhagavas@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: October 31, 2018.
David D. Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2018–24224 Filed 11–5–18; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Prospective Grant of Exclusive Patent
License: Therapeutics for Insulin
Resistance and Non-Alcoholic Fatty
Liver Disease/Non-Alcoholic
Steatohepatitis (NASH/NAFLD)
AGENCY:
National Institutes of Health,
HHS.
ACTION:
E:\FR\FM\06NON1.SGM
Notice.
06NON1
]]>Agencies
[Federal Register Volume 83, Number 215 (Tuesday, November 6, 2018)]
[Notices]
[Page 55556]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-24224]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special
Emphasis Panel; PAR 17-158: Secondary Data Analyses For NIMH
Research Domain Criteria (R03).
Date: November 28, 2018.
Time: 12:00 p.m. to 2:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Telephone Conference Call).
Contact Person: Julius Cinque, MS, Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 5186, MSC 7846, Bethesda, MD 20892, (301) 435-
1252, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member conflict: AIDS and Related Research.
Date: November 29, 2018.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Virtual Meeting).
Contact Person: Shalanda A Bynum, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3206, Bethesda, MD 20892, 301-
755-4355, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Bone and Cartilage.
Date: November 29, 2018.
Time: 12:00 p.m. to 5:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Virtual Meeting).
Contact Person: Richard Ingraham, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4116, MSC 7814, Bethesda, MD
20892, 301-496-8551, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Role of Blood Brain Barrier in Pain and Brain Tumors,
Peripheral Nerve and Brain Injury.
Date: November 30, 2018.
Time: 11:00 a.m. to 12:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Telephone Conference Call).
Contact Person: Seetha Bhagavan, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5194, MSC 7846, Bethesda, MD
20892, (301) 237-9838, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: October 31, 2018.
David D. Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2018-24224 Filed 11-5-18; 8:45 am]
BILLING CODE 4140-01-P
